Abstract
Cytochrome p450 (CYP) enzymes are involved in the metabolism of many psychotropic medications. Genetic polymorphisms can lead to alterations in drug metabolism, leading to toxicity or lack of therapeutic response in patients. Multiple commonly prescribed medications for early psychosis have relevant cytochrome p450 interactions. It is important for clinicians to be aware of these interactions when working with children, adolescents, and transitional-age youth experiencing psychosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
